Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study

Author:

Masotti LucaORCID,Landini Giancarlo,Panigada Grazia,Grifoni Elisa,Tarquini Roberto,Cei Francesco,Cimolato Barbara Maria Angela,Vannucchi Vieri,Di Pietro Massimo,Piani Fiorella,Fortini Alberto,Faraone Antonio,Nenci Gabriele,Cipollini Franco,Blanc Pierluigi,Lotti Pamela,Di Natale Massimo,Risaliti Filippo,Aquilini Donatella,Seravalle Cristiana,Bribani Andrea,Farsi Alessandro,Micheletti Irene,Cioni Elisa,Pelagalli Giulia,Mattaliano Chiara,Pinto Gabriele,Madonia Elisa Maria,Sivieri Irene,Mannini Marianna,Valoriani Alice,Brancati Simona,Rosselli Matteo,Pavone Eleonora,Burla Maria Chiara,Sergi Alessandro

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference38 articles.

1. COVID-19 in Southeast Asia: current status and perspectives;Chu;Bioengineered,2022

2. The emergence of the omicron (B.1.1.529) SARS-CoV-2 variant: what is the impact on the continued pandemic?;Al-Tawfiq;J. Epidemiol. Glob. Health,2022

3. Deciphering the COVID-19 cytokine storm: systematic review and meta-analysis;Mulchandani;Eur. J. Clin. Invest.,2021

4. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity;Osuchowski;Lancet Respir Med.,2021

5. Interleukin-6 as prognosticator in patients with COVID-19;Grifoni;J. Infect.,2020

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3